For a patient with clinically node positive pancreatic cancer, do you simply boost the involved nodes to full dose or treat additional adjacent nodal regions electively?

I would recommend including an elective target volume. In your boost/high dose volume, you can include the involved primary and involved nodes with margin. The elective volume may include regions at risk for occult nodal involvement and pathways of peri-neural spread. This would align with the NRG c...